The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: Report of five exemplary cases

Acta Neurochirurgica

Volumn 151, Issue 10, 2009, Pages 1289-1294

  Niemi, Tomi ^a   Silvasti Lundell, Marja ^a   Armstrong, Elina ^a   Hernesniemi, Juha ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antithrombotic drugs; Bridging therapy; LMWH; Neurosurgery

Indexed keywords

ANTITHROMBOCYTIC AGENT; DALTEPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; FATALITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; MALE; METHODOLOGY; MIDDLE AGED; NEUROSURGERY; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS;

AGED; ATRIAL FIBRILLATION; CEREBRAL HEMORRHAGE; CORONARY ARTERY DISEASE; DALTEPARIN; FATAL OUTCOME; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; VENOUS THROMBOSIS;

EID: 74949136597     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-009-0419-x     Document Type: Article

References (11)

1. Aspinall SL, DeSanzo BE, Trilli LE et al. (2005) Bleeding risk index in an anticoagulation clinic. Assessment by indication and implications for care. J Gen Intern Med 20:1008-1013. doi:10.1111/j.1525-1497.2005.0229.x
2. Caird J, Chukwunyerenwa C, Ali Z et al. (2006) Craniotomy with prosthetic heart valves: a clinical dilemma. Br J Neurosurg 20:40-42. doi:10.1080/ 02688690600603719
3. Cutlip DE, Baim DS, Ho KK et al. (2001) Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 17(103):1967-1971
4. Garcia DA, Regan S, Henault LE et al. (2008) Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 168:63-69. doi:10.1001/archinternmed.2007.23
5. Geerts WH, Pineo GF, Heit JA, et al. (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3)(Suppl):338S-400S. doi:10.1378/chest.126.3-suppl.338S
6. Gerlach R, Tölle F, Raabe A et al. (2002) Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 33:1618-1623. doi:10.1161/01.STR.0000017219.83330.FF
7. Kearon C, Hirsh J (1997) Management of anticoagulation before and after elective surgery. N Engl J Med 336:1506-1511. doi:10.1056/NEJM199705223362107
8. Korinth MC (2006) Low-dose aspirin before intracranial surgery-results of a survey among neurosurgeons in Germany. Acta Neurochir (Wien) 148:1189-1196. doi:10.1007/s00701-006-0868-4
9. Palmer JD, Sparrow OC, Iannotti F (1994) Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 35:1061-1065. doi:10.1097/00006123-199412000-00007
10. Siironen J, Juvela S, Varis J et al. (2003) No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 99:953-959
11. Tetri S, Hakala J, Juvela S, et al. (2008) Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res (in press)